ReciBioPharm Advanced Bio

ReciBioPharm is a leading contract development and manufacturing organization (CDMO) dedicated to the advancement of biologics and advanced therapy medicinal products (ATMPs). Formed through the strategic integration of Arranta Bio, Vibalogics, and GenIbet by parent company Recipharm, the entity provides end-to-end services for complex modalities including viral vectors, mRNA, and live biotherapeutic products. The company supports biopharmaceutical clients from early-stage process development and scale-up through to clinical and commercial-scale GMP manufacturing. With a global footprint across the United States and Europe, ReciBioPharm offers specialized expertise in microbiome-derived therapies and oncolytic viruses. Their facilities are equipped with state-of-the-art technologies to handle the unique challenges of manufacturing next-generation genomic medicines.